The effect of intra-uterine injection of autologous lymphocyte and platelet-rich plasma on the pregnancy rate
Phase 3
- Conditions
- Recurrent implantation failure.Supervision of pregnancy with history of infertilityZ35.0
- Registration Number
- IRCT20221010056132N1
- Lead Sponsor
- Iranian academic center for education culture and research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 96
Inclusion Criteria
Experience at least 2 implantation failures in IVF/ICSI
Primary infertility
Endometrial thickness less than 6 mm at the time of ovulation induction
Age less than 40 years
Regular menstrual cycles
Body mass index<30
Absence of uterine pathology and infection
unexplained infertility
Infertility with tubal causes
Exclusion Criteria
Polycystic ovary syndrome
Uterine pathology
Referring due to male infertility
Presence of hydrosalpinx
Presence of endometriosis.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biochemical pregnancy: through a quantitative beta-human chorionic gonadotropin pregnancy test. Timepoint: 2 weeks after embryo transfer. Method of measurement: Quantitative beta-human chorionic gonadotropin pregnancy test.;Clinical pregnancy: pregnancy confirmed by high levels of human chorionic gonadotropin-beta and ultrasound confirmation of pregnancy sac or heartbeat. Timepoint: Three to five weeks after embryo transfer. Method of measurement: Vaginal ultrasound.
- Secondary Outcome Measures
Name Time Method